Clifford Group, LLC: ORLY position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Clifford Group, LLC on ORLY, newest first. How the timeline and the estimate are built.
Clifford Group, LLC held 2,377 ORLY shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 2,377 sharesChange vs previous 13F +22 shares
0.15% of the 13F portfolio, value $218,898.
13F-HR 0001965522-26-000004 filed by Clifford Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 2,355 sharesChange vs previous 13F +60 shares
0.17% of the 13F portfolio, value $217,390.
13F-HR 0001965522-26-000003 filed by Clifford Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 2,295 sharesChange vs previous 13F 0 shares
0.16% of the 13F portfolio, value $209,327.
13F-HR 0001965522-26-000002 filed by Clifford Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 2,295 sharesChange vs previous 13F 0 shares
0.19% of the 13F portfolio, value $247,424.
13F-HR 0001965522-25-000007 filed by Clifford Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 2,295 sharesChange vs previous 13F +2,142 shares
0.17% of the 13F portfolio, value $206,848.
13F-HR 0001965522-25-000006 filed by Clifford Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 153 sharesChange vs previous 13F not available
0.2% of the 13F portfolio, value $219,185.
13F-HR 0001965522-25-000005 filed by Clifford Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).